Annovis Bio (ANVS) Current Assets (2019 - 2024)
Annovis Bio's Current Assets was $7.81 million in Q1 2024, down 69.4% from $25.55 million a year earlier and down 23.5% from the prior quarter.
Powered by 
Analysis
Annovis Bio (ANVS) Current Assets (2019 - 2024) Analysis & Trends
At the end of FY2023, Current Assets at Annovis Bio came in at $10.21 million, down 71.7% from FY2022.
- Current Assets shows a four-year compound annual growth rate of 92.2% (FY2019 to FY2023).
- In earlier years, Current Assets was $36.02 million in FY2022 (-21.7%), $46 million in FY2021 (+466.6%), $8.12 million in FY2020 (+986.2%) and $747,512 in FY2019.
- The Q1 2024 figure marks the lowest quarterly Current Assets since Q1 2021.
- Compared with a year earlier, Current Assets has declined for eight straight quarters, with an average decline of 45.2% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was Q4 2020 (growth of 986.2%); the worst was Q3 2023 (a decline of 72.5%).
- Per Business Quant data, ANVS's Current Assets in the three quarters before Q1 2024 was $10.21 million (Q4 2023), $10.22 million (Q3 2023) and $22.82 million (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Annovis Bio | 58.80 Mn | 58.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 7.81 Mn |
| Dec 31, 2023 | 10.21 Mn |
| Sep 30, 2023 | 10.22 Mn |
| Jun 30, 2023 | 22.82 Mn |
| Mar 31, 2023 | 25.55 Mn |
| Dec 31, 2022 | 36.02 Mn |
| Sep 30, 2022 | 37.12 Mn |
| Jun 30, 2022 | 39.97 Mn |
| Mar 31, 2022 | 44.10 Mn |
| Dec 31, 2021 | 46.00 Mn |
| Sep 30, 2021 | 47.65 Mn |
| Jun 30, 2021 | 49.50 Mn |
| Mar 31, 2021 | 5.96 Mn |
| Dec 31, 2020 | 8.12 Mn |
| Sep 30, 2020 | 9.40 Mn |
| Jun 30, 2020 | 10.20 Mn |
| Mar 31, 2020 | 11.44 Mn |
| Dec 31, 2019 | 747,512.00 |
API Access
Annovis Bio Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ANVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ANVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ANVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();